Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.
about
The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progressionNovel methodologies for biomarker discovery in atherosclerosisEndothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease studySoluble adenylyl cyclase controls mitochondria-dependent apoptosis in coronary endothelial cellsCirculating apoptotic progenitor cells in patients with congestive heart failure.Effect of different dialysis modalities on microinflammatory status and endothelial damage.Characterization of microparticles after hepatic ischemia-reperfusion injury.Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapyThe involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.Small-size circulating endothelial microparticles in coronary artery diseaseCirculating CD62E+ microparticles and cardiovascular outcomes.Endothelial progenitor cells as factors in neovascularization and endothelial repairCirculating microparticles and endogenous estrogen in newly menopausal women.Increased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients.Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery diseaseEffects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factorsCirculating endothelial microparticles as a measure of early lung destruction in cigarette smokers.Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP.Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production.Endothelial function in migraine with aura - a systematic review.Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae.Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.Endothelial progenitor cells in atherosclerosis.Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in PigsClinical and therapeutical implications of EPC biology in atherosclerosis.Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.Disturbed blood flow acutely induces activation and apoptosis of the human vascular endothelium.Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fractionPromoting vascular regeneration as an alternative to conventional angioplasty-based intervention.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Endothelial progenitor cells in health and atherosclerotic disease.Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.The role of microparticles in inflammation and thrombosis.The impact of insulin resistance on endothelial function, progenitor cells and repair.Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women.Obesity and sexual dysfunction, male and female.Circulating endothelial progenitor cells in cardiovascular disorders.Microvesicles: potential markers and mediators of endothelial dysfunction.
P2860
Q28066054-258F1B14-6397-4A91-BD52-1621A32BA80FQ28088373-4988F770-A380-4574-AD1E-1014517F5BB8Q28386977-BB533710-17EA-44D6-B9C7-FC58EAA2D161Q28571558-B4079E30-2376-47C3-819A-7164D3720E0FQ33370283-60EA08B5-B031-4802-8120-15355C8F2495Q33684098-54C28D04-C141-4354-AC77-C7A61390AE38Q33689943-A08CB10B-953F-4FEC-A51A-686309656889Q33813731-08BB7117-A254-43EB-9D5C-141CCBA1AC91Q33822217-729B9D9C-648A-4147-A5F6-905974078E42Q33916623-8FB0096C-DC93-4754-BB80-C8899245FA1EQ34026858-D1605065-2DE4-4809-88D1-D618DBD2235CQ34035371-262E8B6D-E9F1-40D2-B846-0394082AA2F8Q34259709-A880109C-9CF0-4B27-84D7-F4BBF6EE595BQ34444790-DCDB2C6C-18B2-4F3B-8D9E-DDC2A075C3F3Q34476755-5E2E8397-795D-4F76-BA8C-3228F8459C4EQ34849981-79947493-DB85-47DA-B419-CCFEC83288B7Q35067334-BA7BE213-59E7-4D08-9A2D-CB5D0EB57547Q35158221-6E28B053-E2E3-4F5D-973E-D459FA7968C7Q35212590-E108FA3F-5607-4407-BA73-02747DB0C745Q35225292-2F467BF9-A4C4-480E-BD0C-F875DC3F2ABFQ35233331-432E0659-201E-4744-8DC9-B26E2ABCFFD0Q35535243-BFE9778D-5F99-46EB-94F0-163C0171FFABQ35927423-AE4C88B4-36F6-4306-A6E0-1DC918B22634Q35968665-E2BADF1C-6FE3-4B2E-B704-F4C04EFB7A05Q36011477-941CA1F7-913A-4808-9613-798F623401A6Q36230443-86A5C734-47C3-482A-9388-977C1268CB71Q36517055-AD88D575-DB07-49A1-A45F-878B27ECB844Q36609707-11FD96E3-5751-4DBF-85E2-3E87961B8135Q36630135-C25B3623-3FD4-4C4F-BF82-F18368AA7198Q36645079-29A24E87-29C9-4FBA-B9D5-9644AB86F62CQ36684479-2EE965E4-5A1B-4186-ACD0-4700DC133F7BQ36745194-68E8EC25-88F2-4736-B0B4-F7B8D64472E7Q36799382-6B00043D-B332-40FA-85E0-9196CCCDEA7AQ36816361-6C3C35F1-27B4-40F5-9C66-6697A98088D3Q36884498-3BBD023B-EDBC-48AB-8B78-0519E4ED7A48Q36892494-9F82ADA7-9639-444F-AE99-103258D829FFQ36893365-CC63CCAB-3088-44B7-8952-8E0B7C716CFCQ37133986-BA0457A4-A4D8-4718-985B-3AE136437FF4Q37269391-DF1CCDB2-1F7E-44AE-AE21-3BEC5EE6F28AQ37273154-53BA5EAD-F367-4892-AAB3-FF09F9CBFDE5
P2860
Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Circulating CD31+/annexin V+ a ...... with coronary artery disease.
@en
type
label
Circulating CD31+/annexin V+ a ...... with coronary artery disease.
@en
prefLabel
Circulating CD31+/annexin V+ a ...... with coronary artery disease.
@en
P2093
P1476
Circulating CD31+/annexin V+ a ...... with coronary artery disease.
@en
P2093
Georg Nickenig
Nikos Werner
Patrick Ahlers
Sonja Kosiol
Sven Wassmann
P304
P356
10.1161/01.ATV.0000191634.13057.15
P407
P577
2005-10-20T00:00:00Z